Evidence map›Paper›PMID 39770537›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Zanwen Zuo, Ruihua Wen, Shuang Jing, Xianghui Chen, Ruisang Liu, Jianping Xue, Lei Zhang, Qizhang Li

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Complete mitochondrial genome ofMitochondrial DNA. Part B, Resources · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zanwen ZuoInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Ruihua WenInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Shuang JingInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Xianghui ChenSchool of Medicine, Shanghai University, Shanghai 200444, China.
Ruisang LiuNational "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), School of Life Science and Health Engineering, Hubei University of Technology, Wuhan 430068, China.
Jianping XueInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Lei ZhangInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
Qizhang LiInnovative Drug R&D Center, Innovative Drug Research Center, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.ORCID 0000-0001-7737-7787

Funding

Collaborative Grant-in-Aid of the HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics XBTK-2021006Excellent Scientific Research and Innovation Team of University in Anhui Province 2022AH010029National Key Research and Development Program of China 2022YFC3501700National Natural Science Foundation of China 82225047, 32170274Natural Science Research Project of Anhui Educational Committee 2024AH051675Open Project Funding of the Key Laboratory of Fermentation Engineering (Ministry of Education) 202105FE02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerGanoderma lucidum immunomodulatory proteinluminal Aprognosis improvementprognostic signatureTMEM63C

Identifiers

PMID39770537
PMCPMC11677753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.